Treatment of vitreomacular traction with intravitreal gas injection

Poster Details

First Author: S.Gruchociak FRANCE

Co Author(s):    F. Metge   G. Caputo   C. Arndt                       

Abstract Details


Evaluate safety issues and functional outcome of intravitreal gas injections in case of vitreo-macular traction syndrome


A two centre retrospective chart review was conducted at Rotschild Foundation Hospital and Reims University Hospital


Patients with vitreo-macular traction syndrome (inner retinal changes on optical coherence tomography) responsible for central scotoma, or metamorphopsia or both and subnormal near vision > 0.5 were analyzed 7 days, 1 month and 3 months after an intravitreal gas injection (SF6 or C3F8)


In 6 eyes of 6 patients injected with avec 0.3 ml de SF6 visual acuity remained stable ranged between 1.0 and 0.1 far vision and 0.6 and 0.16 near vision. 7 days after the injection 4 of 6 eyes presented with a posterior vitreous detachment. In eyes in which a posterior vitreous detachment was observed, the greatest diameter of vitreous attachment was below 343 microns meters. No complication was observed at 7 days and 6 months


The results are in accordance with already published data. Intrevireal injection of gas appears as a safe alternative to simple observation or on the contrary a more invasive procedure such as vitrectomy. As in ocriplasmine studies, the largest diameter of vitreoretinal attachment appears to be limiting factor for induced posterior vitreous detachment. A prospective multicentre study should enable the define the place of this procedure for managment of vitreoretinal traction

Back to previous
EURETINA, Temple House, Temple Road, Blackrock, Co Dublin. | Phone: 00353 1 2100092 | Fax: 00353 1 2091112 | Email:

Privacy policyHotel Terms and Conditions Cancellation policy